ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 022,41
-0,01%
Dow Jones
37 986,40
0,56%
DAX
17 737,36
-0,64%
Brent Oil
86,615
0,23%
Bitcoin
64 164,64
1,03%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Cel Sci Corporation New (CVM)

  7. Cel Sci Corporation New (CVM) Actualités

CVM Cel Sci Corporation New

1,55
0,03 (1,97%)
Après les heures de négociation
Dernière mise à jour : 22:00:10
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cel Sci Corporation New CVM AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,03 1,97% 1,55 22:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,54 1,50 1,57 1,55 1,52
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/3/202414:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
07/3/202417:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/3/202417:33EDGAR2Form ARS - Annual Report to Security Holders
06/3/202414:45BWCEL-SCI Corporation Issues Letter to Shareholders
15/2/202414:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
14/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202418:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09/2/202414:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06/2/202415:00BWCEL-SCI Completes Commissioning of Its Multikine..
31/1/202415:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
02/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202322:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202314:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
21/12/202322:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/12/202314:30BWUK’S National Institute for Health and Care Excellence..
20/11/202323:25EDGAR2Form 8-K - Current report
20/11/202322:15BWCEL-SCI Announces Closing of $5 Million Public Offering of..
16/11/202314:30BWCEL-SCI Announces Pricing of $5 Million Offering of Common..
30/10/202322:01EDGAR2Form 8-K - Current report
30/10/202314:20BWCEL-SCI Issues Letter to Shareholders
24/10/202316:18EDGAR2Form 8-K - Current report
24/10/202314:00BWCEL-SCI Releases Video Detailing Recent Phase 3 Findings &..
23/10/202315:15BW5-Year Head & Neck Cancer Survival Increased From 45% to 73%..
19/10/202314:00BWCEL-SCI Readies Its Multikine Manufacturing Facility for..
05/10/202314:45BWCEL-SCI Files Request With the UK’s MHRA Regarding Path to..
03/10/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202315:00BWCEL-SCI Submits Scientific Advice Filing to European..
31/8/202323:16EDGAR2Form 8-K - Current report
11/8/202314:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2023..
10/8/202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/7/202322:10EDGAR2Form 8-K - Current report
20/7/202317:36BWCEL-SCI Announces Closing of Public Offering
18/7/202322:05EDGAR2Form 8-K - Current report
18/7/202303:23BWCEL-SCI Announces Pricing of Public Offering
17/7/202322:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
14/7/202318:25EDGAR2Form 8-K - Current report
14/7/202315:15BWCEL-SCI Concludes Positive Meeting With U.S. FDA Concerning..
12/7/202315:01EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

AMEX
CVM
Cel Sci
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés